Target intelligence / Profile preview

Sodium channel subunit beta-3 (SCN3B)

Target
SCN3B
Molecular classification
Ion channel, Voltage-gated sodium channel auxiliary subunit, Membrane protein
01

Overview

Sodium channel subunit beta-3 (SCN3B) is a membrane protein encoded by the SCN3B gene and serves as an auxiliary regulatory subunit for voltage-gated sodium channels (Nav). These channels are crucial for the initiation and propagation of action potentials in excitable cells such as neurons and cardiac muscle. SCN3B modulates the gating kinetics, especially the inactivation behavior, of sodium channels, thereby influencing electrical signaling and conduction. Its unique extracellular Ig-like domain provides distinct adhesion properties and structural support. SCN3B plays vital roles in cardiac excitability and rhythm; mutations are linked to arrhythmic conditions including Brugada syndrome and familial atrial fibrillation. While no approved drugs directly target SCN3B, it is a key modulator within the sodium channel complex, with potential therapeutic implications for cardiovascular and neurodegenerative diseases. SCN3B also participates in cellular stress signaling, acting via p53-dependent pathways to influence apoptosis and cell proliferation in a context-dependent manner.

Other names
Sodium channel regulatory subunit beta-3SCN3BKIAA1158SCNB3ATFB16BRGDA7HSA243396sodium channel, voltage-gated, type III, beta subunitvoltage-gated sodium channel beta-3 subunit
02

Mechanism of action

Modulation of Nav channel function via alteration of gating and inactivation kinetics (when part of the sodium channel complex); Indirectly affected by sodium channel blockers (e.g., antiarrhythmic agents) acting at the channel level, not specifically at beta-3 subunit

03

Biological functions

Modulation of sodium channel activityRegulation of gating kinetics of voltage-gated sodium channelsInactivation kinetics modulation in sodium channelsCell adhesion (distinct Ig domain–mediated binding)Positive regulation of heart rate, cardiac conduction, and action potential propagationParticipation in signal transduction, especially in neurons and cardiac tissueProtein localization to membrane (nodes of Ranvier in neurons)Modulation of cellular responses via p53 pathway
04

Disease associations

Cardiovascular disease (Arrhythmias, Brugada syndrome, Familial atrial fibrillation, Sudden infant death syndrome)Cancer (oncogenic role in liver cancer cells via p53 regulation)Neurodegenerative or neuropathic pain (as a participant but not a primary cause)
05

Safety considerations

Risk of cardiac arrhythmias with loss-of-function mutations; possible conduction disturbanceOncogenic potential in the context of liver cancer cellular signalingComplexity in tissue- or isoform-specific effects (e.g., targeting could disrupt both neuronal and cardiac tissue electrical activity)
06

Interacting drugs

None currently approved or directly targeting SCN3B; sodium channel blockers generally affect the channel complex, but no drugs selectively target this subunit (Information on direct drugs for SCN3B is currently lacking in the referenced databases.)
07

Biomarkers

Mutational analysis (e.g., A130V variant for arrhythmias/Brugada syndrome)SCN3B mutation as a risk factor and diagnostic marker for cardiac conduction abnormalitiesNo validated pharmacodynamic or efficacy biomarker in current clinical use

Beyond the preview

Go deeper on Sodium channel subunit beta-3 (SCN3B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sodium channel subunit beta-3 (SCN3B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call